Euclidean Capital as of March 31, 2024
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 13 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 65.4 | $510M | 975k | 523.07 | |
| Ishares Tr Msci India Etf (INDA) | 16.0 | $125M | 2.4M | 51.59 | |
| Spdr Gold Tr Gold Shs (GLD) | 11.4 | $89M | 432k | 205.72 | |
| Oric Pharmaceuticals (ORIC) | 1.7 | $14M | 989k | 13.75 | |
| Foghorn Therapeutics (FHTX) | 1.4 | $11M | 1.6M | 6.71 | |
| Alector (ALEC) | 1.0 | $7.9M | 1.3M | 6.02 | |
| Rapt Therapeutics (RAPT) | 0.8 | $5.9M | 658k | 8.98 | |
| 23andme Holding Class A Com (ME) | 0.7 | $5.4M | 10M | 0.53 | |
| Tenaya Therapeutics (TNYA) | 0.7 | $5.3M | 1.0M | 5.23 | |
| Pmv Pharmaceuticals (PMVP) | 0.6 | $4.5M | 2.6M | 1.70 | |
| Ngm Biopharmaceuticals | 0.2 | $1.6M | 992k | 1.59 | |
| Surrozen Com New (SRZN) | 0.2 | $1.4M | 88k | 15.71 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $5.2k | 171k | 0.03 |
